Cargando…
Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review
Real‐world evidence (RWE) is emerging as a fundamental component of the post‐marketing evaluation of medicinal products. Even though the focus on RWE studies has increased in Colombia, the availability of secondary data sources to perform this type of research is not well documented. Thus, we aimed...
Autores principales: | Franco, Juan‐Sebastian, Vizcaya, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510335/ https://www.ncbi.nlm.nih.gov/pubmed/32965783 http://dx.doi.org/10.1002/prp2.661 |
Ejemplares similares
-
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)
por: Langan, Sinéad M, et al.
Publicado: (2018) -
Real-World Evidence: Pharmacoepidemiology for Daily Clinical Practice—An Experience from Colombia
por: Machado-Alba, Jorge Enrique, et al.
Publicado: (2020) -
Pharmacoepidemiological safety studies in children: a systematic review
por: Osokogu, Osemeke U., et al.
Publicado: (2016) -
The Promotion of Data Sharing in Pharmacoepidemiology
por: Sethi, Nayha
Publicado: (2014) -
Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review
por: Gault, Nathalie, et al.
Publicado: (2017)